The Stem Cell Podcast

Guest: Drs. Shuibing Chen and Hans Clevers, members of the Steering Committee for the ISSCR Consortium on Advanced Stem Cell-Based Models in Drug Discovery and Development, explore how stem cell–derived organoids and other new approach methodologies (NAMs) can complement or replace animal models in preclinical research. The discussion highlights the need for standardization, regulatory alignment, and industry collaboration to improve reproducibility, accelerate drug development, and ultimately create more human-relevant and effective therapies.  Building on its long-standing leadership in global standards, ethics, and policy, the ISSCR is uniquely positioned to convene industry, academia, and regulators around this effort. The initiative also reflects the Society’s expanding industry engagement, with industry membership increasing nearly 180% over the past five years – creating new opportunities for strategic partnerships to address shared scientific and translational challenges. Featured P